Innovator Equity Defined Protection ETF - 1 Yr November (ZNOV)
Live price chart, market sentiment, and community perspectives for Innovator Equity Defined Protection ETF - 1 Yr November (CBOE: ZNOV).
Live price chart, market sentiment, and community perspectives for Innovator Equity Defined Protection ETF - 1 Yr November (CBOE: ZNOV).
Watching the 50-day moving average hovering near $27.38 against the current price of $27.75, our desk notes steady consolidation. The asset's market cap sits right around $105 million, reflecting specialized niche demand for defined outcome products mapped directly to the SandP 500 through the November-to-October cycle.
Analyzing the short interest metrics for ZNOV reveals fascinating June volatility. Short interest spiked by 240.2% by June 30th to 46,857 shares from just 13,775 shares mid-month, after previously dropping significantly earlier in June. With average daily volume around 22,261 shares, the short-interest ratio settled at a manageable 2.1 days, representing about 2.7% of the float sold short.
From an institutional capital allocation view, Q2 filings show 72 hedge funds and large institutions holding roughly $61 million. However, the internal churn is notable: while 11 funds opened new positions and 9 increased, 29 reduced and 14 completely closed out. Cetera Investment Advisers notably cut its stake by 35.9% in the first quarter, showing a cautious risk posture among specific advisory networks.
From a risk management framework, the fund relies on FLEX options to construct its defined outcome strategy targeting the SandP 500. Investors entering or holding during the November 1, 2025 to October 31, 2026 outcome period are banking on pre-determined buffers and caps, which blunts direct market exposure but introduces distinct opportunity costs during strong equity rallies.
Looking closely at the historical transaction logs, smaller institutional movements like FSA Advisors ticking up their holdings by 2.9% contrast with larger institutional trims. This divergence suggests that ZNOV is being utilized as a flexible tactical sleeve rather than a core long-term strategic allocation across major wealth management platforms.
Explore plasma cleansing, somatic organ swaps, and BCI.